[{"AccountsPayableCurrent_0_Q3_USD":8265000.0,"OperatingLeaseLiability_0_Q3_USD":6418000.0,"OperatingLeaseCost_3_Q3_USD":1400000.0,"OperatingLeaseCost_1_Q3_USD":500000.0,"OperatingIncomeLoss_3_Q3_USD":-165207000.0,"OperatingIncomeLoss_1_Q3_USD":-53821000.0,"OperatingExpenses_3_Q3_USD":171772000.0,"OperatingExpenses_1_Q3_USD":56258000.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"NetIncomeLoss_3_Q3_USD":-165011000.0,"NetIncomeLoss_1_Q3_USD":-54084000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-92546000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":1483000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-2288000.0,"LongTermDebtNoncurrent_0_Q3_USD":42345000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":8633333.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":6666667.0,"LongTermDebtCurrent_0_Q3_USD":18482000.0,"LongTermDebt_0_Q3_USD":15300000.0,"LiabilitiesCurrent_0_Q3_USD":118239000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":434536000.0,"Liabilities_0_Q3_USD":175410000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":1037000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":512000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":2185000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":47786000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":2250000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":4935000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.084,"StockIssuedDuringPeriodValueStockOptionsExercised_3_Q3_USD":672000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":177000.0,"StockIssuedDuringPeriodValueAcquisitions_3_Q3_USD":5000000.0,"StockholdersEquity_0_Q3_USD":259126000.0,"ShareBasedCompensation_3_Q3_USD":21397000.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_3_Q3_USD":1828000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":6565000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":2437000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-308827000.0,"RestrictedCashNoncurrent_0_Q3_USD":2074000.0,"ResearchAndDevelopmentInProcess_3_Q3_USD":5000000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":5983000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":141127000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":4843000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":8789000.0,"ProceedsFromStockPlans_3_Q3_USD":515000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":672000.0,"ProceedsFromIssuanceOfDebt_3_Q3_USD":46599000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":2288000.0,"PaymentsToAcquireInterestInJointVenture_3_Q3_USD":0.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-1397000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-519000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-2477000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":1394000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":45398000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":26338000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":1987000.0,"InterestPaidNet_3_Q3_USD":173000.0,"ContractWithCustomerAssetNet_0_Q3_USD":2015000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-165011000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-54084000.0,"CommonStockValue_0_Q3_USD":26000.0,"CommonStockSharesOutstanding_0_Q3_shares":26349000.0,"CommonStockSharesIssued_0_Q3_shares":26349000.0,"CommonStockSharesAuthorized_0_Q3_shares":60000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-47048000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":415954000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":413880000.0,"ContractWithCustomerLiability_0_Q3_USD":66113000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":60000.0,"Assets_0_Q3_USD":434536000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":1514023.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":1457223.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":21397000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":6870000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_3_Q3_USD":21397000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":6870000.0,"AdditionalPaidInCapital_0_Q3_USD":567927000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":3946000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":52358000.0,"AccountsReceivableNetCurrent_0_Q3_USD":2015000.0,"AssetsCurrent_0_Q3_USD":420966000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":7455000.0,"ContractWithCustomerLiabilityRevenueRecognized_3_Q3_USD":-6565000.0,"DeferredRevenueNoncurrent_0_Q3_USD":8497000.0,"InterestExpenseLongTermDebt_3_Q3_USD":2000000.0,"InterestExpenseLongTermDebt_1_Q3_USD":700000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":2302000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":35493000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":13569000.0,"IncreaseDecreaseInAccountsReceivable_3_Q3_USD":-110000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-2569000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":0.0,"IncomeTaxExpenseBenefit_1_Q3_USD":0.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":670000.0,"IncomeLossFromEquityMethodInvestments_1_Q3_USD":-250000.0,"DeferredRevenueCurrent_0_Q3_USD":57616000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":30645000.0,"ForeignCurrencyTransactionGainLossRealized_3_Q3_USD":923000.0,"ForeignCurrencyTransactionGainLossBeforeTax_3_Q3_USD":923000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q3_USD":506000.0,"EquityMethodInvestments_0_Q3_USD":670000.0,"EquityMethodInvestmentAggregateCost_0_Q3_USD":9200000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":6376000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-6.27,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-2.05,"Dividends_3_Q3_USD":0.0,"DepreciationAndAmortization_3_Q3_USD":883000.0,"DepreciationAndAmortization_1_Q3_USD":300000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":10860000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":26302000.0,"Ticker":"ARCT","CIK":"1768224","name":"ARCTURUS THERAPEUTICS HOLDINGS INC.","OfficialName":"Arcturus Therapeutics Holdings Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"666232551.0","Country":"Israel","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211109"}]